Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rami Ghazi Melibari"'
Autor:
Alyaa Elhazmi, Awad Al-Omari, Hend Sallam, Hani N. Mufti, Ahmed A. Rabie, Mohammed Alshahrani, Ahmed Mady, Adnan Alghamdi, Ali Altalaq, Mohamed H. Azzam, Anees Sindi, Ayman Kharaba, Zohair A. Al-Aseri, Ghaleb A. Almekhlafi, Wail Tashkandi, Saud A. Alajmi, Fahad Faqihi, Abdulrahman Alharthy, Jaffar A. Al-Tawfiq, Rami Ghazi Melibari, Waleed Al-Hazzani, Yaseen M. Arabi
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 7, Pp 826-834 (2022)
Background: Coronavirus disease-19 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is currently a major cause of intensive care unit (ICU) admissions globally. The role of machine learning in the ICU is ev
Externí odkaz:
https://doaj.org/article/6ed5b710975a4513b356a9778ffd2978
Autor:
Alyaa Elhazmi, Ahmed A. Rabie, Awad Al-Omari, Hani N. Mufti, Hend Sallam, Mohammed S. Alshahrani, Ahmed Mady, Adnan Alghamdi, Ali Altalaq, Mohamed H. Azzam, Anees Sindi, Ayman Kharaba, Zohair A. Al-Aseri, Ghaleb A. Almekhlafi, Wail Tashkandi, Saud A. Alajmi, Fahad Faqihi, Abdulrahman Alharthy, Jaffar A. Al-Tawfiq, Rami Ghazi Melibari, Yaseen M. Arabi
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 6; Pages: 2301
Background: Tocilizumab is a monoclonal antibody proposed to manage cytokine release syndrome (CRS) associated with severe COVID-19. Previously published reports have shown that tocilizumab may improve the clinical outcomes of critically ill patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::353d97ee0f8655d1c4b2dd71d5a3a9b4
Autor:
Alyaa Elhazmi, Awad Al-Omari, Hend Sallam, Hani N. Mufti, Ahmed A. Rabie, Mohammed Alshahrani, Ahmed Mady, Adnan Alghamdi, Ali Altalaq, Mohamed H. Azzam, Anees Sindi, Ayman Kharaba, Zohair A. Al-Aseri, Ghaleb A. Almekhlafi, Wail Tashkandi, Saud A. Alajmi, Fahad Faqihi, Abdulrahman Alharthy, Jaffar A. Al-Tawfiq, Rami Ghazi Melibari, Waleed Al-Hazzani, Yaseen M. Arabi
Publikováno v:
Journal of infection and public health. 15(7)
Coronavirus disease-19 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is currently a major cause of intensive care unit (ICU) admissions globally. The role of machine learning in the ICU is evolving but c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43296d9de115059548eb46816bcea02d
https://pubmed.ncbi.nlm.nih.gov/35759808
https://pubmed.ncbi.nlm.nih.gov/35759808
Autor:
Ahmed A. Rabie, Awad Al-Omari, Hani N. Mufti, Ali Altalaq, Ghaleb A. Almekhlafi, Hend Sallam, Mohamed H Azzam, Fahad Faqihi, Waleed Alhazzani, Ayman Kharaba, Rami Ghazi Melibari, Ahmed Mady, Wail Tashkandi, Abdulrahman Alharthy, Adnan Alghamdi, Yaseen M. Arabi, Zohair Al-Aseri, Jaffar A. Al-Tawfiq, Saud A Alajmi, Alyaa Elhazmi, Anees Sindi, Mohammed Alshahrani
Background:The Coronavirus Disease-19 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a major cause of intensive care unit (ICU) admissions globally. Robust data of epidemiology, characteristics, and disease o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71b2cbd0e1a5af79ecf7ba40f7304437
https://doi.org/10.21203/rs.3.rs-961542/v1
https://doi.org/10.21203/rs.3.rs-961542/v1
